STAGE II OVARIAN CANCER AJCC V8
Clinical trials for STAGE II OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Probiotics may ease chemo side effects in ovarian cancer
Symptom relief Recruiting nowThis study tests whether taking probiotics can improve gut and vaginal health in 161 women with advanced or recurrent ovarian cancer who are receiving platinum chemotherapy. Participants will take either a probiotic or a placebo pill. Researchers will check stool and vaginal samp…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:36 UTC
-
Wearable tech aims to get cancer patients moving for better health
Symptom relief Recruiting nowThis study tests whether a personalized activity program using a Fitbit can help women with advanced ovarian or endometrial cancer exercise more and improve their quality of life. About 120 participants will either get standard care or the automated program. Researchers will also…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
Can your social life help you beat Cancer's aftermath?
Knowledge-focused Recruiting nowThis study follows 250 young adults (ages 18-39) recently diagnosed with cancer to see how their social relationships and physical activity change over time and affect their quality of life. Researchers will track hospitalizations, treatment details, exercise habits, and well-bei…
Matched conditions: STAGE II OVARIAN CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC